Search
2 articles for “Low-density lipoprotein (LDL-C) & High-density lipoprotein (HDL-C)”
-
Review of Atorvastatin As A Potent Drug For Cardio-Vascular Disease(CVD)
Abstract: Cardiovascular disease (CVD), particularly atherosclerosis, remains the leading cause of death worldwide, significantly burdening public health, especially in Western societies. Metabolic syndrome and arrhythmic complications further exacerbate cardiovascular morbidity and mortality. Among restorative specialists, statins particularly atorvastatin have gotten to central in both the essential and auxiliary anticipation of coronary heart infection (CHD) due to their strong lipid-lowering properties and additional pleiotropic impacts. Atorvastatin, a selective HMG-CoA reductase inhibitor, not …
Published in Research & Reviews: A Journal of Drug Design & Discovery · Vol. 12, Issue 3, 2025 · pp. 8–18 Read article
-
A Comparative Study of Lipid Profile in Pre-Dialysis and Post-Dialysis End-Stage Renal Disease Patients
Abstract: Background: Chronic kidney disease (CKD) represents a major public health concern in India, with its prevalence increasing at an alarming rate. Individuals with CKD are at a substantially higher risk of developing cardiovascular disease (CVD), which remains the leading cause of mortality in this population. Dyslipidemia is particularly pronounced among patients with end-stage renal disease (ESRD); however, limited data are available regarding the impact of hemodialysis on lipid profile alterations. …
Published in Research and Reviews: A Journal of Medicine · Vol. 16, Issue 1, 2026 · pp. 25–31 Read article